Syon Capital’s AstraZeneca AZN Stock Holding History

Syon Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.36M	Buy	11,958 +27	+0.2%	+$5.21K	0.12%	124
2025 Q4	$2.19M	Buy	11,931 +427	+4%	+$74.9K	0.11%	143
2025 Q3	$1.77M	Buy	11,504 +802	+7%	+$121K	0.09%	145
2025 Q2	$1.5M	Buy	10,702 +840	+9%	+$118K	0.1%	145
2025 Q1	$1.45M	Buy	9,862 +853	+9%	+$123K	0.12%	128
2024 Q4	$1.18M	Sell	9,009 -516	-5%	-$72.2K	0.11%	139
2024 Q3	$1.48M	Buy	9,525 +137	+1%	+$22.1K	0.13%	115
2024 Q2	$1.46M	Buy	9,388 +489	+5%	+$73.6K	0.13%	113
2024 Q1	$1.21M	Sell	8,899 -10,066	-53%	-$1.33M	0.11%	131
2023 Q4	$2.55M	Buy	18,965 +10,959	+137%	+$1.42M	0.11%	121
2023 Q3	$1.08M	Buy	+8,006	New	+$1.09M	0.14%	96

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Syon Capital's AZN Position: Q1 2026 in Review

Syon Capital increased its AstraZeneca (AZN) stake by 0.23% in Q1 2026, buying an estimated $5.21K and bringing the position to 11,958 shares worth $2.36M. The position accounts for 0.12% of the portfolio, ranked #124.

Syon Capital first reported a position in AZN in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.55M in Q4 2023. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Syon Capital held 11,958 shares of AstraZeneca worth $2.36M as of Q1 2026.
Syon Capital bought 27 AstraZeneca shares in Q1 2026, an estimated $5.21K.
AstraZeneca made up 0.12% of Syon Capital's portfolio in Q1 2026, its #124 holding.
Syon Capital first reported a position in AstraZeneca in Q3 2023 and has held it in 11 quarters since.
Syon Capital's AstraZeneca position peaked at $2.55M in Q4 2023.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.